Skip to main content

What the label lists and what reports show

Alanine, arginine and 22 other ingredients side effects

Alanine, arginine and 22 other ingredients's FDA label: “The most common adverse reactions (≥3%) are hyperglycemia, hypokalemia, pyrexia, and increased blood triglycerides.” FAERS holds 398 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is chills (30 reports).

  • No generic listed

Check it at the source: the alanine, arginine and 22 other ingredients FDA label on DailyMed (effective September 15, 2025); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

The most common adverse reactions (≥3%) are hyperglycemia, hypokalemia, pyrexia, and increased blood triglycerides.

Table 3: Adverse Reactions in >2% of Patients Treated with PERIKABIVEN

Adverse reaction* Terms as reported in clinical studies PERIKABIVEN N=93 (%)
Hyperglycemia5 (5)
Hypokalemia4 (4)
Pyrexia4 (4)
Blood triglycerides increased3 (3)
Phlebitis2 (2)
Nausea2 (2)
Pruritus2 (2)
Gamma-glutamyltransferase increased2 (2)
Blood alkaline phosphatase increased2 (2)
Alanine aminotransferase increased2 (2)
Blood glucose increased2 (2)
C-reactive protein increased2 (2)
Blood urea increased2 (2)
Hypoalbuminemia2 (2)

Rows and numbers as the label prints them, under its own column headings (the first rows of a longer table where it runs on). A reaction in a trial table is not necessarily caused by the medicine, and trials differ from everyday use.

From the label: adverse reactions, continued

The following serious adverse reactions are discussed in greater detail in other sections of the prescribing information. • Clinical Decompensation with Rapid Infusion of Intravenous Lipid Emulsion in Neonates and Infants [see Warnings and Precautions ( 5.1 )]. • Parenteral Nutrition-Associated Liver Disease and Other Hepatobiliary Disorders [see Warnings and Precautions ( 5.2 )]. • Pulmonary Embolism and Respiratory Distress due to Pulmonary Vascular Precipitates [see Warnings and Precautions ( 5.3 )]. • Hypersensitivity Reactions [see Warnings and Precautions ( 5.4 )]. • Precipitation with Ceftriaxone [see Warnings and Precautions ( 5.5 )]. • Infections [see Warnings and Precautions ( 5.6 )]. • Fat Overload Syndrome [see Warnings and Precautions ( 5.7 )]. • Refeeding Syndrome [see Warnings and Precautions ( 5.8 )]. • Diabetes and Hyperglycemia [see Warnings and Precautions ( 5.9 )]. • Hypertriglyceridemia [see Warnings and Precautions ( 5.10 )]. • Vein Damage and Thrombosis [see Warnings and Precautions ( 5.11 )]. • Electrolyte Imbalance and Fluid Overload in Patients with Decreased Renal Function [see Warnings and Precautions ( 5.12 )]. • Aluminum Toxicity [see Warnings and Precautions ( 5.13 )]. The most common adverse reactions (≥3%) are hyperglycemia, hypokalemia, pyrexia, and increased blood triglycerides.

Source: FDA drug label, Fresenius Kabi USA, LLC, effective September 15, 2025 (SPL set c2eb5522-8572-45f4-869d-42f9fd251bb6), via openFDA; the full label on DailyMed

What do FAERS reports show?

398 reports list alanine, arginine and 22 other ingredients among the medicines taken, each a report of something that happened, not proof the medicine caused it; 75 are coded as a death and 212 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 24 reactions below, 9 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

The 25 most reported reactions

  • Chills (named in the label)30
  • Pyrexia (named in the label)24
  • Nausea (named in the label)22
  • Chest Discomfort21
  • Palpitations20
  • Vomiting (named in the label)20
  • Death (an outcome recorded in the report)19
  • Pneumonia19
  • Asthenia18
  • Diarrhoea18
  • Dyspnoea18
  • Foetal Growth Restriction17
  • Anaemia (named in the label)14
  • Rash Maculo-Papular14
  • Cerebral Haemorrhage13
  • Thrombocytopenia (named in the label)13
  • Myalgia12
  • Pruritus (named in the label)12
  • Extravasation11
  • Hepatic Cytolysis11
  • Rash (named in the label)11
  • Tachypnoea11
  • Anaphylactic Shock10
  • Cholestasis (named in the label)10
  • Eosinophilia10

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Alanine, arginine and 22 other ingredients: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions